A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects
Clinical trial NCT03796013 · COMPLETED
Trial details
- NCT number
- NCT03796013
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-10
- Primary completion
- 2019-02-06
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.